中国实用外科杂志

• 专题笔谈 • 上一篇    下一篇

持续或复发性分化型甲状腺癌再手术疗效及其影响因素

董文武,张    浩   

  1. 中国医科大学附属第一医院甲状腺外科,辽宁沈阳110001
  • 出版日期:2021-08-01 发布日期:2021-08-10

  • Online:2021-08-01 Published:2021-08-10

摘要: 持续或复发性分化型甲状腺癌(DTC)病人并不罕见。对于有手术指征且可手术切除的病灶,外科手术是首选的且安全有效的治疗手段,术后病人预后较好。但是,由于持续或复发性DTC病人样本量较少,随访时间较短以及不同研究之间的入组标准和手术范围等方面存在异质性,再手术的临床疗效及其影响因素还有待具有长期随访资料的前瞻性随机临床研究进行验证。

关键词: 甲状腺癌, 再手术, 预后, 危险因素

Abstract: Clinical efficacy and influencing factors of reoperation for persistent/recurrent differentiated thyroid cancer                 DONG Wen-wu,ZHANG Hao. Department of Thyroid Surgery,the First Hospital of China Medical University,Shenyang 110001,China
Corresponding author:ZHANG Hao,E-mail:haozhang@cmu.edu.cn
Abstract    Persistent/recurrent differentiated thyroid cancer (DTC) is not uncommon. Surgery is the preferred, safe and effective treatment for the resectable lesions with surgical indications, and with good prognosis. However, due to the small sample size of patients with persistent/recurrent DTC, the short follow-up time, and the heterogeneity of inclusion criteria and surgical extent among different studies, the clinical efficacy of reoperation and its influencing factors need to be verified by prospective randomized clinical studies with long-term follow-up.

Key words: thyroid cancer, reoperation, prognosis, risk factors